Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan

By sjmartinez • September 22, 2024

Tangri N, Rastogi A, Sofue T. Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan. Adv Ther. 2024 Sep 19. doi: 10.1007/s12325-024-02961-3. Epub ahead of print. PMID: 39298075.

Tags: albuminuria, Chronic kidney disease, dapagliflozin, effectiveness, Epidemiology, Nephrology, Publications, SGLT-2i, Urinary albumin-to-creatinine ratio

Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis

Heerspink HJL, Beernink JM, Agarwal R, Cherney DZI, Lam CSP, Neuen BL, Perkovic V, Tuttle KR, Sarafidis P, Birne R, Chen X, Hornum M, Maldonado[...]

Correction of Alkalemia in a Hemodialysis Patient: A Case Report

Luu YH, Hajmomenian HR, Khorsan R. Correction of Alkalemia in a Hemodialysis Patient: A Case Report. Cureus. 2026 Jul 28;18(7):e113556. doi: 10.7759/cureus.113556. PMID: 42666655; PMCID:[...]

Favorable Adherence and Tolerability of Letermovir Versus Valganciclovir for Cytomegalovirus Prophylaxis in Kidney Transplant Recipients Aged 65 y or Older: Findings From a Randomized, Phase 3 Trial

Bunnapradist S, Vincenti F, Witzke O, Schneeberger S, Nguyen MH, Broyde N, Gilbert CL, Haber B. Favorable Adherence and Tolerability of Letermovir Versus Valganciclovir for[...]